Cytokinetics stockCYTK
Cytokinetics trades at $55.55, 37.1% below its 52-week high (Jun 30, 2026). The price is below its 50- and 200-day averages, a downtrend. −12.6% year to date, −6.1% over 12 months (S&P 500 over the same period: +8.8%). Next earnings report: Mar 2, 2027.
Ratings, candles, signals and the screener for CYTK — after you log in
Open the terminalFrequently asked questions about Cytokinetics
What is the Cytokinetics stock price?
At the close on Nov 5, 2026: $55.55 (−12.66% on the day). 52-week high: $88.31 on Jun 30, 2026. During the session the price is updated with a 15-minute delay, after the close with the day's final figures.
When does Cytokinetics report earnings?
The next quarterly report is on Mar 2, 2027. Last quarter, earnings per share changed +46% year over year, revenue +2,356%.
Does Cytokinetics pay dividends?
No, Cytokinetics does not pay dividends.
Where does Cytokinetics trade and how to buy it?
Ticker CYTK, exchange Nasdaq, listed since 2004. You can buy it through a broker with access to US exchanges.
Should I buy Cytokinetics now?
We do not give buy or sell advice. Ratings, the detailed chart and signals for CYTK are in the terminal after you log in.